F

FOLD

Amicus Therapeutics, Inc.
HealthcareBiotechnology|NASDAQ Global Market|US

Price

$14.44

Market Cap

$4.53B

Beta

0.49

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+20.05%
EPS Growth (YoY)+50.86%
Revenue CAGR 3Y+24.43%
P/E Ratio0.0
PEG Ratio
FCF Yield+0.66%
Debt / Equity1.76
Interest Coverage0.7x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for FOLD.

FOLD — Amicus Therapeutics, Inc. Stock Analysis | Tessera Alpha